Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04552223
Title Nivolumab Plus Relatlimab in Patients With Metastatic Uveal Melanoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Jose Lutzky, MD
Indications

uveal melanoma

Therapies

Nivolumab + Relatlimab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.